Profilo
Daniel Getts is the founder of Cour Pharmaceuticals Development Co., Inc., CREATE Medicines, Inc. (Massachusetts).
Dr. Getts is currently Director at Curate Biosciences since 2022.
Former positions include Director-Research & Development at Tolera Therapeutics, Inc. and Vice President-Research at TCR² Therapeutics, Inc. from 2017 to 2019.
Education includes a doctorate from Northwestern University and graduate and doctorate degrees from The University of Sydney.
Posizioni attive di Daniel Getts
| Società | Posizione | Inizio |
|---|---|---|
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Fondatore | - |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Direttore/Membro del Consiglio | 15/08/2022 |
Precedenti posizioni note di Daniel Getts
| Società | Posizione | Fine |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Fondatore | - |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Corporate Officer/Principal | - |
Formazione di Daniel Getts
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Commercial Services |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Commercial Services |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
















